Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer
-
Apogee Therapeutics to Host Inaugural Virtual R&D Day on December 2, 2024
-
SL Green Realty Corp. Announces Common Stock Dividend
-
Leil Storage Launches EDU & Research Program to Tackle Key Data Storage Challenges in Academic Research
-
Incyclix Bio Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate INX-315 in Combination with Verzenio® (abemaciclib) and Fulvestrant in HR+/HER2- Breast Cancer
-
Steakholder Foods Signs Six Commercial LOIs with International Players; Receives Prestigious Industry Awards
-
OptimizeRx to Participate in Upcoming Investor Conferences
-
Alliance Witan PLC - Net Asset Value
-
Leil Storage Launches EDU & Research Program to Tackle Key Data Storage Challenges in Academic Research
-
Giyani Metals Announces AGM Results
-
Wisdomtree Multi Asset Issuer Public Limited Company (the “Issuer”) Notification of Change in Name of Securities
-
AGF Investments Announces 2024 Estimated Annual Reinvested Capital Gains Distributions for ETFs
-
FBS Highlights the Role of Tokenized Assets in Revolutionizing Global Finance
-
Form 8.3 - [VOLEX PLC] - Opening Disclosure - 15 11 2024 - (CGAML)
-
Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update
-
Form 8.3 - [VOLEX PLC] -15 11 2024 - (CGWL)
-
Samsung Bioepis and Biogen Receive European Commission (EC) Approval for Aflibercept Biosimilar, OPUVIZ™
-
Incident IQ Launches iiQ Resources, a Comprehensive Solution for Instructional Materials Management
-
Verde Reports up to 13,944 ppm TREO 5,222 ppm MREO and 213 ppm DyTb
-
Marimaca Initiates ASX Dual Listing Process
-
GameStop Appoints Nat Turner to Board of Directors
-
Brady Corporation Reports Fiscal 2025 First Quarter Results
-
Kandi Technologies Reports Third Quarter 2024 Financial Results
-
HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate
-
Larimar Therapeutics Presents Additional Data from Phase 1 Studies and Phase 2 Dose Exploration Study Supporting the Nomlabofusp Clinical Program at ICAR 2024
-
Canoo Partners with Northside Truck & Van to Deliver its Initial Parts Network and Reliable Service, Maintenance, and Repair Services to Customers in the United Kingdom
-
Adverum Biotechnologies Announces Positive 52-Week LUNA and 4-Year OPTIC Results, and Provides Key Pivotal Program Design Elements
-
Koryx Copper Appoints Heye Daun as President & CEO, Trevor Faber as COO
-
Skye Bioscience to Participate in Upcoming December Healthcare Investment Conferences
-
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
-
Serve Robotics Appoints Anthony Armenta as Chief Software & Data Officer
-
Goodfood to Report Fourth Quarter and Fiscal Year 2024 Results
-
Striim Unveils 5.0: Real-Time AI Agents for Data Discovery, Integration, and Governance to Modernize Enterprise Analytics and AI-Driven Applications
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Bitdeer Reported Unaudited Financial Results for the Third Quarter of 2024
-
NewGenIvf Enters into a Binding Term Sheet with White Lion Capital for $100 Million Equity Line of Credit, Expandable to $500 Million
-
GigaCloud Technology Inc Ranked No. 1 on Forbes’ List of ‘America’s Most Successful Small-Cap Companies 2025’
-
Canoo Partners with Northside Truck & Van to Deliver its Initial Parts Network and Reliable Service, Maintenance, and Repair Services to Customers in the United Kingdom
-
Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024
-
Mondee Cancels Third Quarter 2024 Financial Results Webcast
-
Cibus to Participate in the 13th Annual Roth Technology Conference
-
Uniper selects Electric Hydrogen’s technology for its 200 Megawatt Green Wilhelmshaven project
-
Prairie Operating Co. Secures Takeaway and Water Disposal Solutions for Full-Field Development through Strategic Midstream Partnerships
-
Rhythm Pharmaceuticals Announces Five Presentations at ESPE 2024, including New Real-world Data in Pediatric Patients with Acquired or Congenital Hypothalamic Obesity Treated with Setmelanotide
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC] - 15 11 2024 - (CGWL)
-
Schouw & Co. share buy-back programme, week 46 2024
-
NMD Pharma Initiates Phase 2 Study of NMD670 in Patients with Charcot-Marie-Tooth Disease Type 1 and 2
-
Immatics Announces Third Quarter 2024 Financial Results, Business Update and First Clinical Data on TCER® IMA402 Targeting PRAME
-
MULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
-
Form 8.3 - [ECKOH PLC] - 15 11 2024 - (CGWL)
